Journal Logo

August 2022 - Volume 276 - Issue 2

  • Keith D. Lillemoe, MD
  • 0003-4932
  • 1528-1140
  • 12 issues per year
  • Surgery 2/279
  • 13.787

Current Issue Highlights



The Efficacy of Liposomal Bupivacaine on Postoperative Pain Following Abdominal Wall Reconstruction: A Randomized, Double-blind, Placebo-controlled Trial

Fafaj, Aldo; Krpata, David M.; Petro, Clayton C.; More

Annals of Surgery. 276(2):224-232, August 2022.

Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days

Truong-Thanh, ; Gariani, Karim; Richard, Jean-Christophe; More

Annals of Surgery. 276(2):233-238, August 2022.


Safety of Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Aijtink, Virginia J.; Rutten, Vera C.; Meijer, Beatrice E.M.; More

Annals of Surgery. 276(2):239-245, August 2022.


The Problem of Appetite Loss After Major Abdominal Surgery: A Systematic Review

Wagner, Martin; Probst, Pascal; Haselbeck-Köbler, Michael; More

Annals of Surgery. 276(2):256-269, August 2022.



Standardizing The Intraoperative Adverse Events Assessment to Create a Positive Culture of Reporting Errors in Surgery and Anesthesiology

Enrico Cacciamani, Giovanni; Sholklapper, Tamir; Dell-Kuster, Salome; More

Annals of Surgery. 276(2):e75-e76, August 2022.


Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma

Cabalag, Carlos S.; Yates, Michael; Corrales, Mariana Benitez; More

Annals of Surgery. 276(2):e120-e126, August 2022.



​Annals of Surgery Open: Perspectives on Surgical History, Education, and Clinical Approaches is now accepting submissions!

annalsofsurgeryjournal.PNG

Learn more about the benefits of publishing in Annals of Surgery Open!

benefits.PNG


​​​​​​​​Annals of Surgery has launched a new initiative to ensure highly impactful papers are fast-tracked to our readers. We select papers that we believe will be of importance to our readers based upon the clinical and social impact that they may have on our profession.

​The benefits to readers and authors:

  • 6 months of free access to selected articles
  • e-publication within 10-14 days upon acceptance
  • full publication in an issue within 3-4 months
  • featured across Annals' social media platforms

Your work is our focus.

​Keith D. Lillemoe, MD
Editor-in-Chief


`